Your browser doesn't support javascript.
loading
Reply to 'The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?' by Damiani G et al.
Avallone, G; Giordano, S; Astrua, C; Merli, M; Senetta, R; Conforti, C; Ribero, S; Marzano, A V; Quaglino, P.
Afiliação
  • Avallone G; Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Giordano S; Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Astrua C; Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Merli M; Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Senetta R; Department of Oncology, Pathology Unit, University of Turin, Turin, Italy.
  • Conforti C; Dermatology Clinic, Maggiore Hospital, Trieste, Italy.
  • Ribero S; Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Marzano AV; Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Quaglino P; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
J Eur Acad Dermatol Venereol ; 36(6): e433-e435, 2022 06.
Article em En | MEDLINE | ID: mdl-35067994
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Penfigoide Bolhoso / Pênfigo / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Penfigoide Bolhoso / Pênfigo / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article